KPL-387
KPL-387-C212
Phase 2 small_molecule active
Quick answer
KPL-387 for Recurrent Pericarditis is a Phase 2 program (small_molecule) at Kiniksa Pharmaceuticals International, plc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Kiniksa Pharmaceuticals International, plc
- Indication
- Recurrent Pericarditis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active